Back to Rankings

ADCT

ADC TherapeuticsC
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart

AI scenario view

RankAlpha Sentiment AI
B+
Bull case
25%
Probability
Target price
$10.50
+231.2% vs current
Most likely
B
Base case
55%
Probability
Target price
$7.50
+136.6% vs current
B-
Bear case
20%
Probability
Target price
$3.50
+10.4% vs current

AI sentiment snapshot

Latest data as of 2026-03-11
Recent news sentiment (30D)
-
Unavailable
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Sentiment proxy
+100.0
Score

AI commentary

Near-term sentiment is event-driven and centered on the March 10 operational update; focus is on cash runway language and amended financing terms for dilution risk and optionality [#8-K-2026-03-10] [#SERP-2]. Published analyst targets remain dispersed, reflecting binary clinical/regulatory outcomes and small-cap volatility [#SERP-1].

RankAlpha Sentiment AI - 2026-03-11
Open full AI memo

Evidence flagged

future-looking catalyst discovery is still SERP-only and has not been confirmed by a primary source

Impact
degraded
Confidence
-

AI events

2026-06-09eventInvestor read-through from amended royalty financingHigh impact

Amended royalty financing materially reduced change-of-control payments through 2027; market interpretation and any follow-on cash actions could change perceived runway and financing premium [#SERP-1].

2026-06-09catalystMarket reaction to 2025 results & operational update (8-K)High impact

Q4/FY2025 results and operational update filed on Form 8‑K (2026-03-10). Investors will focus on disclosed cash runway, near-term milestones, and any stated funding needs to reprice downside/upside expectations [#8-K-2026-03-10].

2027-03-11catalystRegulatory/comparative-compendia pathway decisionsHigh impact

Management indicated intent to assess regulatory and compendia routes contingent on positive data. Formal interactions, submissions, or articulated strategy would be a multi-quarter value inflection tied to program-specific outcomes [#8-K-2026-03-10].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo
As of 2026-03-11 • Updated nightlySource: Internal modelMethodology